Downstream purification continues to pressure the biopharmaceutical manufacturing industry from a capacity standpoint, with recent increases in upstream yield and titers overcoming the relatively slow ...

Crystallization often sits at the heart of product quality, yield, and downstream efficiency. For many plants, the choice ...

Alternatives to Traditional Unit Operations Are Now Available to Alleviate Very Real Logjams Due to the complexity of therapeutic protein purification, downstream bioprocess bottlenecks can arise from ...

Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As ...

Saudi Aramco will invest more than $100 billion in chemicals over the next 10 years while seeking “a better balance between our upstream and downstream segments,” says the company’s president and ...

Master of Biotechnology program (MBP) student Anita Huang looks back on her six-month internship at UCB in the United Kingdom and what she learned from the experience. In 2019, two students in ...

“However, the downstream equipment presents a much bigger challenge due to the significant investment required to add capacity to the proofer and oven, if possible at all,” he pointed out. “Another ...

LONDON--(BUSINESS WIRE)--Quantzig is one of the world’s leading analytics solutions providers, committed to offering cutting-edge analytics solutions to help organizations institutionalize data-driven ...

The inspection technology company continues to find solutions for processors as they face tightening USSDA and FSMA ...